http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006233882-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad79175f99031889a8c8fdde32a1cdad |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate | 2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da9168441c87d977b916a84f3e834841 |
| publicationDate | 2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006233882-A1 |
| titleOfInvention | Osmotic dosage form |
| abstract | The present invention is directed to a modified release dosage form for delivering at least one pharmaceutically active ingredient. The dosage form has a first immediate release core for an active ingredient and an osmotic core or osmotic chamber containing at least one pharmaceutically active ingredient that can be the same or a different active ingredient contained in the first immediate release core. A shell having one or more portions surrounds the first immediate release core and osmotic core/chamber. The osmotic chamber includes a barrier layer that is substantially impermeable to the pharmaceutically active ingredient contained therein. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008105752-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017100350-A1 |
| priorityDate | 2005-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 431.